The Fetal Bovine Serum Market is being driven by Rising adoption of stem cell applications
The Fetal Bovine Serum Market is expected to grow at a CAGR of 6.1% during 2024 and 2029. During this period, the market is also expected to show a growth of USD 364.2 million. The Fetal Bovine Serum (FBS) market has experienced significant growth in recent years due to the increasing demand for new pharmaceutical products resulting from the global rise in chronic diseases. FBS plays a crucial role in cell-based research and development, particularly in cell culture testing. Its utilization in various applications, such as biotechnology research, vaccine manufacturing, cloning, and in vitro fertilization, surpasses the requirements for cell growth media. FBS enhances the growth medium, providing comprehensive information on the mechanism and mode of action of medicines through effective cell-based screening.
Get more information on Fetal Bovine Serum Market by requesting a sample report
The market is segmented based on
According to Technavio, There are several factors that are causing the market to flourish during the forecast period, which are as follows:
However, the market also witnesses some limitations, which are as follows:
Rich Experience: 20+ years leading global market research, trusted insights across industries.
Unlock Business Potential with Technavio: Maximize ROI with Technavio's tailored market research: deep dives and actionable insights.
Your Guide to Market Success: Empower your business with Technavio's market research and future-proof your decisions.
Market Scope |
|
Report Coverage |
Details |
Page number |
210 |
Base year |
2024 |
Historic period |
2019-2023 |
Forecast period |
2025-2029 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.1% |
Market growth 2025-2029 |
USD 364.2 million |
Market structure |
Fragmented |
YoY growth 2024-2025(%) |
5.4 |
Key countries |
US, Germany, China, UK, Canada, US, Germany, China, UK, Canada, France, Japan, India, Italy, and South Korea |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Find out which segment is leading the market by accessing the free PDF report
The Fetal Bovine Serum (FBS) market plays a pivotal role in the biotechnology sector, particularly in cell culture media for applications in biopharmaceutical research, clinical trials, regenerative medicine, and pharmaceutical research. FBS is essential for biomanufacturing processes involving protein expression, gene editing, monoclonal antibody production, and in-vitro applications. Serum alternatives are being explored for innovation in areas like stem cell therapies, antibody development, molecular biology, and cell line development. The biotech industry's growth is driven by biotech startups focusing on therapeutic solutions, protein synthesis, vaccine development, and biotech education. FBS patents play a crucial role in the industry's intellectual property landscape.
The Fetal Bovine Serum (FBS) market is a significant segment of the larger life science tools and services industry. FBS, a critical component in embryo culture and cell growth media, is derived from the blood of fetal bovine. Its use is prevalent in various applications, including drug discovery, biologics production, and research in contract research organizations (CROs). The FDA-regulated animal serum is a rich source of essential nutrients for cell growth and proliferation. The expanding healthcare sector, driven by an aging population and increasing incidence of chronic diseases, fuels the demand for advanced research tools and services. Technavio projects that the global life science tools and services market, which includes the FBS market, will experience substantial growth due to this demographic shift and the resulting increase in research and development activities. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/
Safe and Secure SSL Encrypted